Purpose. With more than 120 species, the genus Mycoplasma is one of the largest taxa in the class Mollicutes, a group of micro-organisms that are characterized by apparent simplicity and to which important animal pathogens belong. Mycoplasma bovis is the most frequently identified pathogenic Mycoplasma in cattle; however, the prevalence of other Mycoplasma species living in calves' airways is poorly understood. The aim of this work was to characterize the respiratory tract mycoplasma populations in calves on one of the largest dairy farms in Italy using a real-time PCR assay and a DNA microarray assay.
INTRODUCTION
Bovine respiratory disease (BRD) is the most prevalent disease in cattle, the principal cause of death in weaned dairy heifers and a major cause of economic losses for the cattle industry [1, 2] . The economic losses include the cost of animal replacement, treatment costs, decreased feed efficiency and reduced animal product quality [3] .
As with many other infections, BRD is determined by interactions between the host, several pathogens and the environment. The environmental factors involved in BRD can vary, but usually include stressors such as weaning, shipping, change in nutrition and new social interactions after shipping. All of these factors are variable among individual animals, deeply interconnected and put the animals in a stress condition that is hard to estimate and understand thoroughly [3] [4] [5] . Among the pathogens involved in BRD, the bacterial agents most commonly isolated include Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis. These organisms are found during mortality events and are reported together with inflammatory damage to the lungs [6] . These bacterial agents can live on the mucous membrane surfaces of the respiratory airways as commensals [7] [8] [9] and are able to damage the lung tissue if host defences are impaired due to stress conditions and/or previous or concurrent viral or other Mycoplasma infections [10] [11] [12] . Immunity is fundamental for controlling pathogens, but it has been observed that the commensal bacterial community is able to regulate microbial populations in the respiratory airways of ruminants [13] . For instance, the aerobic bacteria living in the bovine upper respiratory tract showed the ability to both enhance and inhibit the growth of M. haemolytica, P. multocida and H. somni in vitro [14] . Moreover, an inverse relationship has been observed between opportunistic pathogens and commensal bacterial populations living in the human nostrils and oropharynx [15] . For this reason, it is important to study commensal bacteria populations in order to better understand BRD and then find new methods to reduce its prevalence.
Little information is available concerning the prevalence of infections with two or more species of Mycoplasma [16] . There is lack of information regarding both single animals and animal groups, which limits additional investigations on the synergistic/competitive relationships resulting from each bacteria combination. Further, there is evidence showing that the host specificity of mycoplasmas in animals is not strict [17] . The difficulty of culturing mycoplasmas in vitro is a major obstacle to research on and laboratory diagnosis of these fastidious organisms. PCR assays have been used to detect a number of Mycoplasma species, but it is not practical for a laboratory to have PCR tests for each of the 125 mycoplasmas that are currently recognized. On the other hand, DNA microarray testing gives us the opportunity to use a large number of detection probes in order to cover discriminatory gene segments and/ or different genomic regions belonging to several bacteria. In this way, DNA microarray testing is conducted with a high degree of parallelism and is able to achieve greater diagnostic resolution than normal PCR.
Most of the published studies about respiratory airway microbiota in cattle have focused on the pathogenic bacteria associated with BRD [18] . This focus neglects the presence and role of other coexisting bacteria, including other mycoplasmal species. Furthermore, bovine respiratory diseases have principally been studied in feedlot calves, and what information there is on dairy breeds mainly concerns Mycoplasma causing mastitis.
The objectives of this study were (1) to investigate evidence for M. bovis in the respiratory airways of non-vaccinated dairy calves using a real-time PCR method, (2) to characterize non-M. bovis Mycoplasma species living in the respiratory airways of the same calves using a DNA microarray and (3) to see if there is any correlation between the presence/absence of Mycoplasma species and the respiratory clinical status of the animals. The final goal was to better understand the routes of transmission of this pathogen within an endemic farm.
METHODS

Animals and samples
The study group for this investigation included 49 dairy calves under the age of 4 weeks belonging to one of the largest dairy farms in Italy. This farm consists of 3300 animals in total, with an average of 1100 lactating cows. The total number of calves under the age of 4 weeks present in the farm at the different sampling times ranged from 115 to 160. The calves were kept in individual metal hutches with slatted floors elevated from the ground. All calves received colostrum immediately after birth and for their first 3 days of life. Between day 4 and day 70 after birth the diet consisted of milk replacer and concentrates.
One nasal swab and one trans-tracheal aspiration were collected from each calf. These samples were collected by the farm veterinarians, who already screen for respiratory infections by collecting these samples. The samples were collected in 3 different months, August 2015 (16 calves), November 2015 (16 calves) and February 2016 (17 calves).
The calves were selected randomly by the farm veterinarians. The clinical status of the selected calf was evaluated at the same time. None of the calves sampled had received any vaccinations. The clinical BRD signs for each calf were quantified using the Wisconsin clinical scoring system. This scoring system uses five clinical signs (nasal discharge, ocular discharge, head tilt or ear position, induced or spontaneous cough and rectal temperature), subdivided into four levels of severity (from 0 to 3) [19] . Animals were considered to be BRD-positive if the total clinical score (TCS) was !4.
A sterile swab, moistened with sterile phosphate-buffered saline (PBS) solution, was rotated over the mucosal surfaces of both the right and the left nasal cavities, placed in a sterile tube, kept on ice and shipped to the laboratory within 12 h of collection. Trans-tracheal aspirations were performed as follows: the skin of ventral part of the neck, approximately 10 cm from the larynx, was shaved and disinfected using iodophors (Betadine, Meda Pharma) and 70 % alcohol. The animals were injected with 0.1-0.2 mg kg À1 xylazine (Nefrasin 100, Ati) for sedation and, after an injection of 0.5 ml 2 % lidocaine (Lidocaina 2 %, Esteve), a longitudinal skin incision of 2 cm was made right above the trachea. During the whole procedure another veterinarian wearing latex gloves held the animal, extending the head and the neck. An intraflon 12G (Kruuse, Langeskov, Denmark) was inserted between two cartilage rings to enter the trachea lumen. A dog urinary catheter was passed through the Intraflon1 and glided down in the trachea until more than light resistance was felt. Approximately 30-40 ml of sterile 0.9 % NaCl solution was injected into the catheter and immediately aspirated. After changing to a new needle, the aspirate was aseptically injected into a sterile red top tube. The final sample generally consisted of 8-10 ml of aspirated fluid. The whole sampling procedure was performed by a trained veterinary surgeon in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Both the nasal swabs and the trans-tracheal wash were transported on ice to the diagnostic laboratory of the Veterinary Medicine Department at the University of Perugia.
DNA extraction and Mycoplasma spp. screening PCR Upon arrival at the laboratory, DNA was extracted from nasal swabs and trans-tracheal aspirations using the QIAamp DNA mini kit (QIAgen, Hilden, Germany) according to the manufacturer's instructions. After extraction, DNA samples were kept frozen at À80 C until use. A screening PCR for Mycoplasma spp. was carried out as reported by Lierz et al. [20] . The 16S rRNA gene was amplified by PCR using the primers MGSO and GPF (Table 1) . Only PCR-positive samples were selected for further testing.
M. bovis real-time PCR
The real-time PCR for M. bovis was performed as described by Sachse et al. [21] . Briefly, the primer pair PMB996-F/ PMB1066 R and the probe Mbovis1016 targeting the 3¢-terminal region of the oppD gene were used in a duplex reaction with an internal control PCR. The recombinant plasmid pGEM-EGFP2rev [22] was used as a template for the internal amplification control, IC2 (Intype IC-DNA, Qiagen, Hilden, Germany). 
DNA microarray
A DNA microarray assay targeting two different genes within the Mycoplasma genome, 23S rRNA and tuf, and able to detect more than 70 Mycoplasma species at once, was used. This assay is an enhanced version of the one previously developed by Schnee et al. [23] , which was able to detect approximately 40 Mycoplasma species. The two DNA regions were amplified before being analysed. For the prehybridization amplification, the 23S rRNA gene signature region was amplified using the 5¢-biotinylated primers F1388 and R1982, resulting in a 600 bp amplicon [23] . The 5¢-biotinylated primers tuf-064F and tuf-681R were used to amplify the 620 bp tuf target region in a duplex reaction together with an internal control PCR, as described by Schnee et al. [23] . Prehybridization amplification reactions were run on a real-time platform as follows: the reaction mix consisted of 1 µl (10-100 ng) of template, 500 nM of each primer (both forward and reverse) and 10 µl of NyNAmo Flash SYBR Green qPCR Mastermix (Finnzymes, Vantaa, Finland). Deionized water was added to the mixture, resulting in a final volume of 20 µl. The following temperature/time profile was used: initial denaturation at 95 C for 10 min and 40 cycles (95 C for 30 s, 52 C for 30 s and 72 C for 60 s) with subsequent dissociation curve analysis. The reaction was run on an Mx3000P thermocycler and then analysed using MxPro 4.10 software (Agilent, Waldbronn, Germany).
After amplification, DNA microarray hybridization was conducted using the MycoplasmaType AS-5 kit [24] , together with the Identibac hybridization kit (Alere, Jena, Germany) following the manufacturer's instructions. Briefly, 1 µl of the PCR products (0.5 µl of product from each real-time PCR) was diluted in 99 µl of hybridization buffer, warmed to 95 C for 5 min and placed on ice for 2 min. The mix was transferred onto the conditioned array strip (AS) wells for DNA hybridization at 50 C for 60 min. After two washing steps at 45 C for 10 min the strip was incubated with horseradish peroxidase-streptavidin conjugate solution at 30 C for 10 min and washed at 30 C. Seramun Grün (100 µl) was added as a peroxidase substrate in order to visualize the reactive spots on the array. All of the incubation steps were carried out while the reaction mixes were shaken horizontally at 550 r.p.m. on a BioShake iQ (Quantifoil Instruments, Jena, Germany). The ArrayMate transmission reader (Alere, Jena, Germany) was used Table 2 ). The latter was always detected in samples that also tested positive for M. dispar. A total of 33 out of 49 nasal swabs (67.3 %) tested positive for M. dispar and 2 of them (4.1 %) were also positive for M. bovirhinis. Out of the 49 trans-tracheal aspirations, 39 (79.6 %) tested positive for M. dispar and 6 of them (12.2 %) were also positive for M. bovirhinis. When both samples were considered, 37 out of 49 calves (75.5 %) harboured M. dispar in both the upper and lower respiratory airways (see Table 3 ).
Three calves (6.1 %) belonging to the third sampling group (February) had a TCS !4, meaning that they were BRDpositive according to the Wisconsin Clinical Score chart. All of these clinically BRD-positive calves tested positive for M. dispar but tested negative for M. bovirhinis.
We did not detect a statistically significant difference for prevalence between the three sample groups (AugustFebruary) for either nasal swabs (P=0.24) or trans-tracheal aspirations (P=0.5). We also failed to detect a statistically significant difference for Mycoplasma species between the upper and the lower respiratory tract samples.
DISCUSSION
In the present survey we explored Mycoplasma species living in the respiratory tract of non-vaccinated dairy calves housed in one of the largest dairy farms in Italy. Historically, M. bovis has been responsible for roughly 8 % of mastitis cases yearly in the farm. An average of 1.5 % of BRD calf clinical cases are reported per year. This farm experienced an increase of BRD cases in calves (16 % of subjects under the age of 4 weeks) during the previous winter (2014) (2015) . During the sampling period (August-February), the BRD prevalence was 9.3 % among young calves. Of the cohort of calves in this study, TCS for BRD was found in 3 (6.1 %).
Both nasal swabs and trans-tracheal aspirations were used to investigate the upper and the lower respiratory tract of the animals for the prevalence of Mycoplasma spp. A total of 85.7 % of the animals were positive for Mycoplasma species, as determined by PCR.
The prevalence of Mycoplasma found in this study group is higher than that found in other studies. In a recent study of feedlot cattle it was reported that Mycoplasma (M. dispar and M. bovirhinis) was the most common genus (53 %) found in the nasopharynx of a beef cattle group studied 40 days after arrival at the feedlot [25] . Earlier studies had shown that there was a very low prevalence of this genus (0-14.9 %) compared to others in feedlot cattle nasopharynx [13, 26] . It is unclear whether the higher prevalence found in this dairy was related to a different animal breed, different management practices or other undefined factors.
M. bovis is the pathogenic Mycoplasma most frequently identified in cattle [11] . Because of its proven ability to cause pneumonia alone in 4-week-old calves [27] and the presence of this organism on the study farm, a previously reported real-time PCR assay was used to determine the prevalence in a cohort of calves. We were interested in observing whether calves can become infected during the first 4 weeks of life, in order to better understand the routes of transmission of this pathogen within the farm. Surprisingly, M. bovis was circulating in the study dairy farm, causing mastitis in a minor percentage of cows (8 % of mastitis cases), but none of the samples from any of the calves were positive for this species. Our expectation was that we would find this species in young calves, because it is believed that the animals can become infected with M. bovis via the respiratory tract, but also from the teat canal or the genital tract of the cow [28] . Furthermore, the colonization sites for Mycoplasma spp., such as the mucosal surfaces of eyes, nasal cavities, vestibular fossa and ears [29] , may be associated with mastitis [30] .
Even though the calves in this farm are fed with colostrum from healthy cows, they stay in close contact with their own 
mothers for a few hours after birth, which could allow the transmission of the pathogen if the mother is infected. It is possible that a reason for the low prevalence in this study is the fact that the calves received a high level of maternal antibodies against the bacteria, which were effective in hindering the invasion of the calf's respiratory tract by M. bovis. It is also possible that the M. bovis presence in calves was at a very low level, which could not be detected, but this seems unlikely, given the high sensitivity of real-time PCR. Another possibility is that the transmission of the pathogen was avoided through good calf management reducing the exposure. That said, it is likely that the calves will be exposed to the pathogen later in their lives, but it still remains to determined when and how this will happen.
Information on the prevalence of M. bovis in Italy is limited. One publication [31] found that 37 % of lung samples taken from 224 less-than-1-month-old dairy calves in Italy were positive for Mycoplasma spp. at the time of slaughter, 31 % of which was M. bovis (11.6 % of the study group). Radaelli et al. [32] in northern Italy found that 25 % of pneumonic cases in older (6-24 month) beef cattle at slaughter were positive for M. bovis by PCR, while 100 % were serologically positive. However, unlike our research, the previously published studies analysed lung samples from slaughtered animals. Furthermore, the testing in the previous studies was with a qualitative PCR assay. The addition of real-time PCR and DNA microarray technology allows us to determine not only the prevalence of M. bovis, but also the species of other Mycoplasma in the respiratory tract of dairy calves. Finally, this report describes the detection of organisms from samples collected from live animals, not slaughter samples.
The previous studies were conducted in northern Italy (Piedimont, Lombardy, Veneto and Emilia Romagna), where there is a high concentration of dairy farms [31, 32] . The current study describes a completely different population of animals in a dairy farm located in Rome, which is geographically distant from the above-mentioned Italian regions and therefore characterized by different climatic conditions.
Many studies have been performed on dairies in other geographically distant locations. Similar to our results, Angen et al. [33] were not able to detect M. bovis by PCR in any of the trans-tracheal aspirates collected from both healthy and diseased calves from six different dairy herds in Denmark, despite a high detection rate for M. dispar and M. bovirhinis in their study. During a study on the bacteria involved in dairy cattle bronchopneumonia in Brazil, the researchers did not report which species were found in 56 % of Mycoplasma spp.-positive samples [34] .
In our study, the DNA microarray assay detected M. dispar and M. bovirhinis in 42 (85.7 %) and 8 (16.3 %) calves, respectively. M. dispar and M. bovirhinis are globally distributed in bovine populations and have been detected in the respiratory airways of both healthy and diseased cattle [34] [35] [36] . M. dispar is fastidious to culture in vitro and requires both specific media and long incubation times. In addition, its identification is challenging, since early passages do not display typical colony morphology, and nor do they react with hyperimmune serum [37] . In culture, this species can easily be overgrown by M. bovirhinis or other less fastidious bacteria when they are present in the same sample. This overgrowth can result in false negative culture results. Since M. dispar may be missed in general epidemiological surveys utilizing culture, the DNA microarray assay proved to be very useful for the present epidemiological survey, detecting the bacterium in 73.5 % of the Mycoplasma spp.-positive samples.
It is difficult to assess the disease significance of both M. dispar and M. bovirhinis. Little is known of the presence of M. dispar in the environment, but transmission is believed to mostly be by close and repeated contact [11] . It is known that M. dispar is able to cause pneumonia after experimental infection, but the disease generally is not severe. It may be that this Mycoplasma initiates the pathogenic processes that help other organisms to invade the respiratory airways of the animal [38] .
M. bovirhinis was more frequently detected in trans-tracheal aspirations (six calves) than in nasal swabs (two calves), and it was always detected together with M. dispar. After experimental infections with M. bovirhinis no clinical signs were observed in the animals, thus the bacterium is not considered to be a primary pathogen [39] . However, just like M. dispar, it may have a secondary role in disease as its isolation is increased in calves with pneumonia [40] . Additionally, M. dispar and M. bovirhinis are frequently detected together with other organisms causing infection, such as M. bovis, M. haemolytica, P. multocida and H. somni, and may be responsible for exacerbating symptoms induced by these bacteria. The presence of these other non-mycoplasma pathogens was not investigated in the present study, making it impossible to draw any conclusions about this possibility.
The prevalence of Mycoplasma obtained in this study was higher in the trans-tracheal aspiration samples (79.6 %) than in the nasal swabs (67.3 %). These results suggest that trans-tracheal aspirations might be a better sample for detecting mycoplasmas in young calves. While it is true that trans-tracheal aspiration is the best way to prevent contamination of a sample by collecting material from the lower airways, the procedure is invasive and requires veterinary/farm worker time, which results in additional costs. On the other hand, nasal swab samples are easy and inexpensive to collect. Interestingly, even though M. bovirhinis was detected more frequently in trans-tracheal aspirates (six samples) compared to nasal swabs (two samples), the detection of the organism came from only one of the two sample types when they were collected from the same animal. While this may be because of the low numbers of positive animals in this study, it is possible that choosing to perform only one of the two sampling techniques would result in a decrease in the detection of mycoplasmas in sick animal diagnostics or future studies.
Since the majority of tested calves did not show any respiratory signs at the time of sampling, it may be the case that, just as Timsit et al. [25] found, the Mycoplasma species detected are an integral part of the nasopharyngeal microbiota in healthy cattle and therefore probably innocuous. However, it must be kept in mind that M. dispar is closely related -both phenotypically and genetically -to other pathogenic mycoplasmas, such as M. ovipneumoniae and M. hyopneumoniae [41] . Given that M. dispar can cause mild respiratory signs in calves, its presence might not be detected by veterinarians. Further, it might be the case that M. dispar was present in a portion of the 77.1 % Mycoplasma spp. PCR-positive pneumonic calf lungs that Giovannini et al. [31] did not further identify to a species level, eventually causing and/or contributing to the lesions observed. Nevertheless, pulmonary lesions were not investigated in the present survey, so their presence cannot be completely excluded, leaving the question of the real role of M. dispar as a major respiratory pathogen in young calves open.
Conclusion
Our results confirm those of previously published works and, as called for in the current literature, expand our knowledge of the diversity of Mycoplasma populations in the respiratory airways of cattle. Indeed, a very young population was investigated -animals under the age of four weeks -belonging to a category of animals -dairy cattle -that had never been investigated by DNA microarray assay on samples from live animals. Although we detected M. dispar in a high number of calves, the real distribution of this species in the dairy cattle population and its pathogenic role remain unknown. This report provides an important basis for future research to determine how the presence of M. bovis relates to disease in dairy farms, as well as the relationship between exposure and disease in the various dairy farm facilities. As a matter of fact, given the fact that the calves did not harbour M. bovis in this time frame, it is crucial to pinpoint the exact moment at which the animals are exposed to the pathogen during their life on this farm, which suffers from endemic M. bovis.
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